Skip Navigation Links
Front Page
About GNSExpand About GNS
CommunitiesExpand Communities
EducationExpand Education
Links Directory
Medicine & Science
Opinion/ForumExpand Opinion/Forum
Public Safety

Washington D.C.
Culberson Votes to Finalize House’s Historic Opioid Work
News Release
Friday, June 22, 2018

Washington, D.C. – Congressman John Culberson (TX-07) today issued the following statement after the House completed work on 53 bills to combat the opioid crisis, and passed as one bill -  H.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

“Drug addiction and opioid abuse are exploding in our local communities and claim the lives of 115 people across our nation every day. The package of bills passed by the House this week fights back against this terrible scourge.

“We will save lives through a holistic approach to ending this epidemic by improving treatment, expanding recovery support, investing in prevention resources, giving our law enforcement better tools to get drugs out of our neighborhoods, and by cracking down on fentanyl.

“I’m proud to support this comprehensive, bipartisan effort to fight the opioid epidemic. I urge my Senate colleagues to swiftly pass this bill and send it to President Trump’s desk.”

Overview of Key Provisions in H.R. 6, the SUPPORT for Patients and Communities Act:


  • Require state Medicaid programs to have safety controls in place for opioid refills, monitor concurrent prescribing of opioids and certain other drugs, and monitor antipsychotic prescribing for children (H.R. 5799)
  • Provide additional incentives for Medicaid health homes for patients with substance use disorder (H.R. 5810)


  • Instruct the Centers for Medicare and Medicaid Services (CMS) to evaluate the utilization of telehealth services in treating SUD (H.R. 5603)
  • Create a pass-through payment extension under Medicare to encourage the development of non-opioid drugs (H.R. 5809)
  • Incentivize post-surgical injections as a pain treatment alternative to opioids by reversing a reimbursement cut for these treatments in the Ambulatory Service Center setting, as well as collect data on a subset of codes related to these treatments (H.R. 5804)

Public Health

  • Direct the Food and Drug Administration (FDA) to issue or update guidance on ways existing pathways can be used to bring novel non-addictive treatments for pain and addiction to patients. Several approaches have proven successful in speeding the availability of treatments for serious conditions through the FDA (H.R. 5806)

Remembering Jim Guidry

Guidry News Service is headquartered in Midtown Houston.
at 4001 Fannin Street, Suite 4109, Houston, TX. 77004-4077
(409) 763 NEWS(6397)
© 1996, Guidry News Service. Duplication of any part of this website in any manner is prohibited.